09.15.23 -- Balanced Sourcing Of Custom Media/Buffer Formulations: The Case For Outsourcing

We address the additional compliance challenge in biopharma of the requirement of complex analytical instruments that are not traditionally used in highly regulated labs.

Manufacturers with proven expertise in areas such as viral vector production and analytics are needed now more than ever to get breakthrough, deliverable gene editing therapies to patients.

Choosing a CDMO that is agile, innovative, and exhibits a willingness to invest in new equipment, infrastructure, and services will allow the innovator company and the CDMO to grow together.

Examine considerations regarding the handling and process for fill/finish to ensure the stability and purity of your vaccine as well as to limit unnecessary waste and cost.

Even as alternative methods such as PCR and NGS have emerged, in vivo tests have stubbornly remained a central part of testing. Examine current in vivo methods and modern alternatives.

This use case demonstrates a solution that empowers users by connecting to all relevant data sources to visually represent batches and perform analytics with process data.

Explore AAV-based gene therapy production to manage adherent and suspension processes, and new approaches for creating large-scale AAV production that can meet any product specification.

This short webinar explores what is already known about cell culture media analysis, reviews at-line methods for cell culture media analysis, and shares recent data from two case studies.

Explore opportunities with the introduction of high-capacity protein A resins, how and when multicolumn chromatography is beneficial, and how emerging technologies can address bottlenecks.